跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUPRELORIN 4.7 MG IMPLANT - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SUPRELORIN 4.7 MG IMPLANT
Authorized
STANDARD
SUPRELORIN 4.7 MG IMPLANT
VIRBAC AH, INC.
🇨🇦 Health Canada
Approval Date
Feb 5, 2026
Approval ID
abbc6f95ceaa5709
Company
VIRBAC AH, INC.
Type
Standard
Approval Details
Approval Id
abbc6f95ceaa5709
Drug Approval Canada Name
SUPRELORIN 4.7 MG IMPLANT
Product Name
SUPRELORIN 4.7 MG IMPLANT
Status
Marketed
Status Date
2025-03-18
Original Market Date
2023-08-02
Drug Class
Veterinary
Dosage Form
Implant
Route Of Administration
Subcutaneous
Schedule
Prescription
Atc Original
Not Applicable
Aig Number
0127552003
Company Name
VIRBAC AH, INC.
Company Address
Po Box/Cp 162059 Fort Worth Texas United States 76161
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 5, 2026
Approval ID
abbc6f95ceaa5709
Type
Standard
Back to Health Canada Approvals